Open Access

What does the future hold for patients on oral anticoagulants?

Topic: Stroke
Sponsored by Boehringer Ingelheim

Congress Session

About the speaker

Doctor Jonathan Halperin

Mount Sinai Medical Center, New York (United States of America)
11 presentations
0 follower

4 more presentations in this session

Forward thinking about reversal: RE-VERSE AD study.

Speaker: Professor C. Pollack (Philadelphia, US)

Thumbnail

Dabigatran reversal when the unexpected happens.

Speaker: Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

OAC choice: what’s really important for physicians and patients.

Speaker: Professor G. Lip (Liverpool, GB)

Thumbnail

Audience Q&A - Anticoagulation care: covering all the bases.

Speaker: Doctor J. Halperin (New York, US) Doctor J. Eikelboom (Hamilton, CA)

Thumbnail

Access the full session

Anticoagulation care: covering all the bases

Speakers: Doctor J. Halperin, Professor C. Pollack, Doctor J. Eikelboom, Professor G. Lip, Doctor J. Halperin...
Thumbnail

About the event

Image

ESC CONGRESS 2017

26 August - 30 August 2017

Sessions Presentations

Related content

Open Access

Welcome and introduction.

21 May 2022

EHRA Premium Access

Effectiveness and safety of edoxaban in 27,333 patients from ETNA-AF with and without a history of intracranial haemorrhage after 2 years of treatment

4 April 2022

ESC Premium Access

Comparative effectiveness and safety of edoxaban vs warfarin in patients with atrial fibrillation: a nationwide cohort study

28 August 2021

This platform is supported by

logo Novo Nordisk